Medius Deal Watch January 2018
One key question for 2018 is whether the recent US tax changes will have an...
Read MoreThe headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.
Remember:
Get our executive insight into your inbox
Written By
Medius Associates
7 February 2018
One key question for 2018 is whether the recent US tax changes will have an...
Read MoreKey learnings: STORM Therapeutics is developing small molecule inhibitors o...
Read MoreAndrew J. Holman, Co-Founder and Chief Executive Officer at Inmedix, talks ...
Read MoreFiona Nielsen, Founder and Chief Executive Officer at Repositive, explains ...
Read MoreStéphane Boissel, Chief Executive Officer at TxCell, talks to PharmaVenture...
Read MoreDieter Willbold, Founder and Chairman of the Supervisory Board at Priavoid,...
Read MoreElaine Warburton OBE, Chief Executive Officer at QuantuMDx, discusses the c...
Read MoreThe landscape of innovation and investment in the healthcare sector has cha...
Read MoreIP portfolio management is often overlooked, but is extremely important if ...
Read MoreHealthcare is the hottest new sector for start-ups when it comes to new tec...
Read MoreOn Tuesday 6 February 2018, leading life sciences companies will share thei...
Read MoreOn Tuesday 6 February 2018, leading life sciences companies will share thei...
Read MoreThe Drugs & Dealers Blog provides genuine thought leadership, exclusive executive insight and market intelligence on the life science and healthcare investment sector.
© 2018 All Rights Reserved By Biotech and Money
Add Your Response